ArticleLeukemia2016

The novel PI3K-δ inhibitor TGR-1202 enhances Brentuximab Vedotin-induced Hodgkin lymphoma cell death via mitotic arrest.

S L Locatelli et al.PubMed ↗Publisher ↗

No numbers read from the abstract.